[go: up one dir, main page]

AU2003302499A1 - Methods for antigen masking of red blood cells resulting in reduced hemolysis - Google Patents

Methods for antigen masking of red blood cells resulting in reduced hemolysis

Info

Publication number
AU2003302499A1
AU2003302499A1 AU2003302499A AU2003302499A AU2003302499A1 AU 2003302499 A1 AU2003302499 A1 AU 2003302499A1 AU 2003302499 A AU2003302499 A AU 2003302499A AU 2003302499 A AU2003302499 A AU 2003302499A AU 2003302499 A1 AU2003302499 A1 AU 2003302499A1
Authority
AU
Australia
Prior art keywords
methods
blood cells
red blood
cells resulting
reduced hemolysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003302499A
Other versions
AU2003302499A8 (en
Inventor
Basha Clark
Adonis Stassinopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerus Corp
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of AU2003302499A8 publication Critical patent/AU2003302499A8/en
Publication of AU2003302499A1 publication Critical patent/AU2003302499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2003302499A 2002-12-04 2003-12-03 Methods for antigen masking of red blood cells resulting in reduced hemolysis Abandoned AU2003302499A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US43121302P 2002-12-04 2002-12-04
US43121602P 2002-12-04 2002-12-04
US43121502P 2002-12-04 2002-12-04
US43121402P 2002-12-04 2002-12-04
US60/431,216 2002-12-04
US60/431,214 2002-12-04
US60/431,215 2002-12-04
US60/431,213 2002-12-04
PCT/US2003/038224 WO2004050848A2 (en) 2002-12-04 2003-12-03 Methods for antigen masking of red blood cells resulting in reduced hemolysis

Publications (2)

Publication Number Publication Date
AU2003302499A8 AU2003302499A8 (en) 2004-06-23
AU2003302499A1 true AU2003302499A1 (en) 2004-06-23

Family

ID=32475715

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2003298827A Abandoned AU2003298827A1 (en) 2002-12-04 2003-12-03 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU2003297614A Abandoned AU2003297614A1 (en) 2002-12-04 2003-12-03 Novel activated polyethylene glycol compounds
AU2003293237A Abandoned AU2003293237A1 (en) 2002-12-04 2003-12-03 Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003302499A Abandoned AU2003302499A1 (en) 2002-12-04 2003-12-03 Methods for antigen masking of red blood cells resulting in reduced hemolysis

Family Applications Before (3)

Application Number Title Priority Date Filing Date
AU2003298827A Abandoned AU2003298827A1 (en) 2002-12-04 2003-12-03 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU2003297614A Abandoned AU2003297614A1 (en) 2002-12-04 2003-12-03 Novel activated polyethylene glycol compounds
AU2003293237A Abandoned AU2003293237A1 (en) 2002-12-04 2003-12-03 Methods for reacting an antigen masking compound with red blood cells with high efficiency

Country Status (2)

Country Link
AU (4) AU2003298827A1 (en)
WO (4) WO2004050848A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521174B2 (en) * 2003-12-05 2009-04-21 Albert Einstein College Of Medicine Of Yeshiva University Universal red blood cells, methods of preparing same, and uses thereof
CN102108119A (en) 2009-12-25 2011-06-29 天津键凯科技有限公司 Multi-arm polyethylene glycol derivatives and their conjugates and gels with drugs
EA201890149A1 (en) 2015-06-26 2018-07-31 Сирус Корпорейшн COMPOSITIONS OF CRYOPRECIPLES AND METHODS OF THEIR RECEPTION
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
AU2017382449B2 (en) 2016-12-23 2024-10-24 Cerus Corporation Systems and methods for testing and screening using compound bound substrates
BR112019018273A2 (en) 2017-03-03 2020-07-14 Cerus Corporation kits and methods for preparing pathogen inactivated platelet compositions
TWI821233B (en) 2017-12-29 2023-11-11 美商西勒斯股份有限公司 Methods for treating biological fluids, pathogen inactivated biological fluids prepared by the methods, and systems for treating biological fluids
CA3143213A1 (en) 2019-06-22 2020-12-30 Cerus Corporation Biological fluid treatment systems
WO2020264421A1 (en) 2019-06-28 2020-12-30 Cerus Corporation System and methods for implementing a biological fluid treatment device
MX2024010825A (en) * 2022-03-07 2024-09-17 Icoat Medical Ab New use of peg-phospholipid molecules.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292906A (en) * 1962-10-30
US6312685B1 (en) * 1998-03-13 2001-11-06 Timothy C. Fisher Red blood cells covalently bound with two different polyethylene glycol derivatives
US20020042043A1 (en) * 2000-05-31 2002-04-11 Adonis Stassinopoulos Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity

Also Published As

Publication number Publication date
WO2004050848A2 (en) 2004-06-17
AU2003293237A8 (en) 2004-06-23
WO2004049914A2 (en) 2004-06-17
AU2003293237A1 (en) 2004-06-23
AU2003298827A1 (en) 2004-06-23
AU2003297614A8 (en) 2004-06-23
WO2004050029A3 (en) 2004-10-21
WO2004050029A2 (en) 2004-06-17
AU2003302499A8 (en) 2004-06-23
AU2003297614A1 (en) 2004-06-23
WO2004050897A3 (en) 2004-08-26
AU2003298827A8 (en) 2004-06-23
WO2004049914A3 (en) 2005-02-24
WO2004050897A2 (en) 2004-06-17
WO2004050848A3 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
EP1554026A4 (en) Red blood cell processing systems and methods which control red blood cell hematocrit
AU2003237110A1 (en) Improved tubing set for blood handling system and methods of use
AU2003265522A1 (en) FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
AU2003209059A1 (en) Human monoclonal antibodies against membrane proteins
AU2003207973A1 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
AU2003302499A1 (en) Methods for antigen masking of red blood cells resulting in reduced hemolysis
AU2002316162A1 (en) Method of increasing anti-neugc antibody levels in blood
AU2002950611A0 (en) Blood flow analysis system
AU2003243576A1 (en) Method and system for detecting ventricular suction
AU2003277610A1 (en) Method of examining cancer cells and reagent therefor
AU2002321440A1 (en) Expression of modified antibodies in avian cells
EP1341467A4 (en) Method for precipitating red blood cells
AU2002319080A1 (en) Method for the diagnosis and therapy of renal cell carcinoma
AU2003217743A1 (en) Magnetic immobilization of cells
AU2003226441A1 (en) Methods of identifying putative effector proteins
AU2003266225A1 (en) Obtaining and use of therapeutic antibodies entering into the cell
AU2003258690A1 (en) Method for the identification of proteins specific for renal cell carcinoma and use thereof
AU2003901053A0 (en) Blood pack and samples pre-id system
AU2002346654A1 (en) Dialysis catheter set and method of using same
HK1068095A (en) Purification of red blood cells by separation and diafiltration
AU2003905636A0 (en) Method of blood collection
AU2002312893A1 (en) Method for detecting blood cell antigens and the antibodies in response to the same
AU2003239569A1 (en) Analyte microdetector and methods for use
AU2003270518A1 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
AU2002313239A1 (en) Method of analyzing protein occurring in cell or substance interacting with the protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase